← Leaderboards
David N Finegold
University Of Pittsburgh At Pittsburgh
$1,194,206
Attributed
$1,194,206
Total exposure
9
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,194,206 · 9
By mechanism
R01$1,080,933 · 1
M01$113,273 · 8
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jennifer R Grandis$109,711,044
- Alexander D Sorkin$18,987,111
- Jill M Siegfried$10,296,579
- Surinder Kumar Batra$34,830,369
- Mary L Marazita$48,708,804
Others in their field
Top investigators on “Autosomal Dominant Trait”
- Jean-Laurent Casanova · Rockefeller University$10,789,934
- Peter C. Harris · Mayo Clinic Rochester$7,632,460
- Bruce D Gelb · Icahn School Of Medicine At Mount Sinai$7,514,819
- Stefan Neubauer · University Of Virginia$7,234,062
- Christopher M Kramer · University Of Virginia Charlottesville$7,234,062
- Louis J. Ptacek · University Of Utah$6,100,895
Research focus
Autosomal Dominant TraitAutosomal Recessive TraitBiopsyClinical ResearchDisease /Disorder ClassificationEnzyme ActivityFamily GeneticsGene ExpressionGene MutationGenetic DisorderGenotypeGrowth Factor ReceptorsHuman Genetic Material TagHuman SubjectImmunocytochemistryLinkage MappingLymphedemaPhenotypePolymerase Chain ReactionProtein KinaseQuestionnairesReceptor ExpressionVascular Endothelial Growth Factors
Grant awards (11)
TRTMT FABRY DISEASE USING RECOMB GALACT A: AN OBSERV MULT DOSE FABRAZYME$50,632
M01 · FY2005 · RR
TREATMENT OF GAUCHER DISEASE USING GLUCOCEREBROSIDASE INFUSIONS$29,646
M01 · FY2005 · RR
AN OBSERVATIONAL STUDY OF PATIENTS WITH FABRY DISEASE$9,831
M01 · FY2005 · RR
MC, OL STUDY SAFETY/EFFICACY OF FABRZYME W/FABRY DISEASE PREV IN AGAL-008-00$8,327
M01 · FY2005 · RR
A PH4 MC RAND DOSE FREQ EFFICACY CEREZYME INFUSIONS 4 WKS VS 2 WKS$6,995
M01 · FY2005 · RR
TREATMENT OF GAUCHER DISEASE USING GLUCOCEREBROSIDASE INFUSION$4,518
M01 · FY2005 · RR
AN OBSERVATIONAL STUDY OF MUCOPOLYSACCCHARIDOSIS TYPE I (MPS I)$2,657
M01 · FY2005 · RR
GENETIC STUDIES OF LYMPHEDEMA$667
M01 · FY2005 · RR
GENETIC STUDIES OF LYMPHEDEMA$365,278
R01 · FY2002 · HD
GENETIC STUDIES OF LYMPHEDEMA$351,572
R01 · FY2001 · HD
GENETIC STUDIES OF LYMPHEDEMA$364,083
R01 · FY2000 · HD